Cat No.
CEI-0465
Description
An anti-diabetic (antihyperglycemic) drug of the dipeptidyl peptidase-4 (DPP-4) class. Inhibition of the enzyme DPP-4 is thought to increase Glucagon-like peptide-1 (GLP-1) which inhibits glucagon release, stimulates the insulin release and lowers blood glucose.
Alias
MK-0431
Synonyms
MK-0431
CAS No.
654671-77-9
Product_Overview
A DPP4 inhibitor
Targets
DPP4
Chemical Name
7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate
M.Wt
486.61
Purity
>95% by HPLC
Appearance
Off-white solid
Solubility
DMSO or EtOH
Storage
-20 centigrade
Shipping Conditions
Gel pack
Handling
Protect from air and light
Usage
For Research Use Only! Not For Use in Humans.
